PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
15-Jul-2024 Integrated DNA Technologies Announces New Licensing Agreement with SeQure Dx to Advance CRISPR-based Therapeutics Integrated DNA Technologies
15-Jul-2024 ViiV Healthcare to announce data from largest head-to-head randomised clinical trial for 2-drug regimen Dovato against 3-drug regimen Biktarvy at AIDS 2024 ViiV Healthcare
13-Jul-2024 GDP Training Course is Now Ready and Free Pharma Lessons
12-Jul-2024 Clinion Wins The Technology Innovation Leadership Award by Frost & Sullivan Clinion Inc
11-Jul-2024 Socioeconomic status significantly affects fertility treatment outcomes, new study shows European Society of Human Reproduction and Embryology
11-Jul-2024 Familial endocrine diseases linked to increased risk of pregnancy loss, new research shows European Society of Human Reproduction and Embryology (ESHRE)
11-Jul-2024 Envirotainer invests in new testing chambers to drive innovation Envirotainer
11-Jul-2024 Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors Quell Therapeutics
11-Jul-2024 NICE recommends Ebglyss (lebrikizumab) for use in moderate to severe Atopic Dermatitis in the NHS England in eligible adolescents and adults Almirall
11-Jul-2024 Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic Dermatitis Q32 Bio Inc
11-Jul-2024 validation of its AAA EndoStapling solution Aortoseal Endoron Medical
11-Jul-2024 Simris Biologics enters into a collaboration agreement with New Zealand Universities to develop peptide drug conjugates (PDC) Simris Group AB
11-Jul-2024 Cambridge Cognition secures Innovate UK grant for Bio-Hermes 2 project Cambridge Cognition Holdings plc
11-Jul-2024 FLiRTing with danger? Keep calm and carry, within reason, says Covid testing expert London Medical Laboratory
11-Jul-2024 Pan Cancer T secures €4.25 Million in Seed Extension Round to advance next-generation T cell therapies Pan Cancer T
11-Jul-2024 AskBio receives FDA Fast Track and MHRA Innovation Passport designations for AB-1005 investigational GDNF gene therapy for Parkinson’s disease AskBio
11-Jul-2024 Phase Ib completed and the recommended phase II dose is set in the ongoing KANDOVA study Kancera
11-Jul-2024 Cambridge Cognition secures Innovate UK grant for Bio-Hermes 2 project Cambridge Cognition Holdings plc
11-Jul-2024 Oracle Advances Safety Case Management for Life Science Organizations Oracle Life Sciences
11-Jul-2024 Priory signs a new five-year agreement with Ashtons Ashtons